Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epitranscriptomics in parasitic protists: Role of RNA chemical modifications in posttranscriptional gene regulation. | PLoS Pathog | 2022 | 36548245 | PubTator, text mining | PubMed |
| Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis. | Front Endocrinol (Lausanne) | 2022 | 36545327 | PubTator, text mining | PubMed |
| Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients. | Front Genet | 2022 | 36544487 | PubTator, text mining | PubMed |
| Role of m6A modification and novel circ_0066715/ miR-486-5p/ ETS1 axis in rheumatoid arthritis macrophage polarization progression. | Aging (Albany NY) | 2022 | 36541909 | PubTator, text mining | PubMed |
| RNA methylation in vascular disease: a systematic review. | J Cardiothorac Surg | 2022 | 36536469 | PubTator, text mining | PubMed |
| HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells. | Respir Res | 2022 | 36536402 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. | BMC Med Genomics | 2022 | 36528763 | PubTator, text mining | PubMed |
| N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer. | Front Oncol | 2022 | 36523987 | PubTator, text mining | PubMed |
| Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis. | Front Genet | 2022 | 36523766 | PubTator, text mining | PubMed |
| Environmental and social determinants of thyroid cancer: A spatial analysis based on the Geographical Detector. | Front Endocrinol (Lausanne) | 2022 | 36523594 | PubTator, text mining | PubMed |
| Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas. | Transl Cancer Res | 2022 | 36523307 | PubTator, text mining | PubMed |
| Amentoflavone and methyl hesperidin, novel lead molecules targeting epitranscriptomic modulator in acute myeloid leukemia: in silico drug screening and molecular dynamics simulation approach. | J Mol Model | 2022 | 36522514 | PubTator, text mining | PubMed |
| Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis. | Front Pharmacol | 2022 | 36518679 | PubTator, text mining | PubMed |
| RNA m6A modification: Mapping methods, roles, and mechanisms in acute myeloid leukemia. | Blood Sci | 2022 | 36518594 | PubTator, text mining | PubMed |
| Epitranscriptomics in myeloid malignancies. | Blood Sci | 2022 | 36518589 | PubTator, text mining | PubMed |
| METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner. | PeerJ | 2022 | 36518278 | PubTator, text mining | PubMed |
| Biological and pharmacological roles of m6A modifications in cancer drug resistance. | Mol Cancer | 2022 | 36517820 | PubTator, text mining | PubMed |
| SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C. | Cell Death Dis | 2022 | 36513634 | PubTator, text mining | PubMed |
| An overview of the effects and mechanisms of m6 A methylation on innate immune cells in sepsis. | Front Immunol | 2022 | 36505499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=80